BCL-Xl Is Qualitatively Different From and Ten Times More Effective Than BCL-2 When Expressed in a Breast Cancer Cell Line
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-6-213
Full Text
Open PDFAbstract
Available in full text
Date
August 23, 2006
Authors
Publisher
Springer Science and Business Media LLC